Episode Summary
Dr. Anil Makam — hospitalist, health services researcher at UCSF, and faculty at Zuckerberg San Francisco General — joins Drs. Koka and DiGiorgio for a wide-ranging conversation on the hidden mechanics of American healthcare. Makam breaks down long-term acute care hospitals (LTACHs): what they're for, how regional variation and perverse payment incentives have distorted their use, and what the 2016 site-neutral payment reforms actually did to the market. The conversation then shifts to Makam's research on clinical practice guidelines — specifically his 2018 study showing that the majority of ATS recommendations were grounded in low-quality evidence, many carrying strong designations anyway — and what that means for how clinicians should read and apply guidelines at the bedside. The episode closes on the FDA, indication creep, the limits of central planning in quality measurement, and what it actually means to be a good doctor in a system where you can't buy your way to better medicine.
Chapter Markers
00:00 Introduction — Dr. Anil Makam, UCSF hospitalist and health services researcher
02:09 What is an LTACH? Origins, optimal use cases, and the vent-weaning niche
08:09 How clinical practice led Makam to study LTACH utilization
10:08 Geographic variation in LTACH use — decomposing what drives it
14:16 Post-acute care economics: DRGs, payment systems, and perverse incentives
19:11 Medicare Advantage denial rates and the two-tier access problem
23:06 Market access vs. total closures: what the 100 LTACH closures actually mean
24:04 Short-stay outlier rules and the "magical recovery" at the payment threshold
26:07 Site-neutral payment reform and its effects on the LTACH market
31:51 Moving to guidelines: evidence vs. recommendations
33:38 The ATS guidelines study — what they found and the Twitter fallout
39:34 How to practice when most of what we do lacks strong evidence
43:38 Why guidelines are getting more confident on less evidence
47:10 The generalist vs. specialist lens on evidence appraisal
53:47 How do you measure what makes a doctor good?
56:41 Three buckets of physician quality: technical, relational, cognitive
01:00:06 Running a trial vs. appraising a trial — two different skills
01:05:16 Indication creep and applying trial evidence to the wrong patients
01:09:24 The FDA, Vinay Prasad, Marty McCary, and why reform failed
01:13:45 Wrap-up and where to find Makam
Co-Host Handles
@anish_koka and @drdigiorgio
Show Handle
@drsloungepod
Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod
